|
?:authorAffiliation
|
-
[\'Helsinki University, Division of Anesthesiology, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Clinical Research Institute Helsinki University Hospital, Helsinki, Finland.\', \'Clinical Research Institute Helsinki University Hospital, Helsinki, Finland.\', \'HUSLAB, Clinical Chemistry, Helsinki University Hospital and University of Helsinki.\', \'Department of Bacteriology and Immunology and Translational Immunology Research Program, University of Helsinki, Finland.\', \'Department of Bacteriology and Immunology and Translational Immunology Research Program, University of Helsinki, Finland; HUSLAB, Helsinki University Hospital, Finland.\', \'Meilahti Infectious Diseases and Vaccine Research Center, MeVac, Department of Infectious Diseases, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.\', \'Institute of Biomedicine, University of Turku, Turku, Finland.\', \'Institute of Biomedicine, University of Turku, Turku, Finland; Turku University Hospital, Clinical Microbiology, Turku, Finland.\', \'Department of Hematology, Coagulation Disorders Unit, Helsinki University Hospital, Helsinki, Finland; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland; Finnish Institute for Health and Welfare, Helsinki, Finland. Electronic address: riitta.lassila@hus.fi.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}